中文名称: | 雷沙吉兰 | ||||
---|---|---|---|---|---|
英文名称: | Rasagiline | ||||
别名: | 雷沙吉兰 Azilect;HSDB 7699;1-Indanamine, N-2-propynyl-, (R)- | ||||
CAS No: | 136236-51-6 | 分子式: | C12H13N | 分子量: | 171.24 |
CAS No: | 136236-51-6 | ||||
分子式: | C12H13N | ||||
分子量: | 171.24 |
基本信息
产品编号: |
R10142 |
||||
产品名称: |
Rasagiline |
||||
CAS: |
136236-51-6 |
储存条件 |
粉末 |
2-8℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
两年 |
||
分子量 |
171.24 |
-20℃ |
1个月 |
||
化学名: |
(R)-N-(prop-2-ynyl)-2,3-dihydro-1H-inden-1-amine;(R)-N-(2-Propynyl)-2,3-dihydroinden-1-amine |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
34 mg/mL (198.55mM) |
|||
Ethanol |
34 mg/mL (198.55mM) |
||||
Water |
4 mg/mL (23.35mM) |
||||
体内(现配现用): |
1.请依序添加每种溶剂:10% DMSO→40% PEG300→5% Tween-80 →45% saline Solubility: ≥ 2.5 mg/mL (14.60mM); Clear solution |
||||
此⽅案可获得 ≥ 2.5 mg/mL (14.60mM,饱和度未知) 的澄清溶液。 以 1mL ⼯作液为例,取 100μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400μL PEG300 中,混合均匀;向上述体系中加⼊ 50μL Tween-80,混合均匀;然后继续加⼊ 450μL ⽣理盐⽔定容⾄ 1mL。 |
|||||
2.请依序添加每种溶剂:10% DMSO→90% (20% SBE-β-CD in saline) Solubility: ≥ 2.5 mg/mL (14.60mM); Clear solution |
|||||
此⽅案可获得 ≥ 2.5 mg/mL (14.60mM,饱和度未知) 的澄清溶液。以 1mL ⼯作液为例,取 100μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900μL 20% 的 SBE-β-CD ⽣理盐⽔⽔溶液中,混合均 匀。 |
|||||
3.请依序添加每种溶剂:10% DMSO→90% corn oil Solubility: ≥ 2.5 mg/mL (14.60mM); Clear solution |
|||||
此⽅案可获得 ≥ 2.5 mg/mL (14.60mM,饱和度未知) 的澄清溶液,此⽅案不适⽤于实验周期在半个⽉以上的实验。 以 1mL ⼯作液为例,取 100μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900μL ⽟⽶油中,混合均匀。 |
|||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
5.8398mL |
29.1988mL |
58.3976mL |
5mM |
1.1680mL |
5.8398mL |
11.6795mL |
10mM |
0.5840mL |
2.9199mL |
5.8398mL |
50mM |
0.1168mL |
0.5840mL |
1.1680mL |
生物活性
产品描述 |
一种选择性的、不可逆的丙炔胺抑制剂。 |
||
靶点 |
MAO-B |
MAO-A |
|
4.43nM |
412nM |
||
体外研究 |
Rasagiline (0.25 nM; 96 hours) significantly increases the proliferation rates of SH-SY5Y and 1242-MG upon Dexamethasone (10 µM) treatment. Cell Proliferation Assay |
||
Cell Line: |
Neuroblastoma SH-SY5Y, and glioblastoma 1242-MG |
||
Concentration: |
0.25nM |
||
Incubation Time: |
96 hours |
||
Result: |
Caused ~60% increase in the cell proliferation rate for SH-SY5Y cells treated with Dexamethasone. Caused ~35% increase in cell proliferation rate for 1242-MG cells treated with Dexamethasone. |
||
体内研究 |
Rasagiline is neuroprotective in a transgenic model of multiple system atrophy. Motor behavioural tests show improvements in motor deficits associated with 2.5 mg/kg Rasagiline therapy |
||
Animal Model: |
(PLP)-α-synuclein transgenic mice over 6 months of age |
||
Dosage: |
Low-(0.8 mg/kg b.w.) and high dose (2.5 mg/kg b. w.) |
||
Administration: |
Administered subcutaneously every 24 h for a total period of 4 weeks (from day 1 till day 28 of the experiment). |
||
Result: |
Low dose treatment did not show protective efficacy in striatum with number of neurons similar to placebo treated MSA mice. High dose was associated with about 15% rescue of DARPP-32 immunoreactive striatal neurons. Low dose treatment had no effect on nigral neuronal loss, but high dose completely protected nigral neurons with numbers comparable to healthy controls. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )